Friday, 26 February 2027

Registration, Welcome Coffee & Networking

Welcome Address

Session 1: Setting the Scene: The Current Reality for an IRD Patient

Session 2: Developing Innovative Therapies: Challenges & Opportunities

Lunch & Networking

Session 3: An Introduction to IRDs & Genotyping: Current Technology & Interpretation of Results

Session 4: Phenotyping Part 1: Imaging

Session 5: Phenotyping Part 2: Visual Electrophysiology & Psychophysics

Session 6: Case Presentations

Reception & Networking

Saturday, 27 February 2027

Registration, Welcome Coffee & Networking

Session 7: Generalised Retinal & Chorioretinal Dystrophies

Moderated Poster Tour

Session 8: Macula-Predominant Dystrophies & Stable Disorders

Lunch & Networking

Session 9: Inherited Optic Neuropathies

Session 10: Therapies for IRDs – Part 1

Session 11: Therapies for IRDs – Part 2

End of Programme

Reception & Networking

Organizing Committee

• Bart LeRoy – Belgium, Euretina Board Member

• Marko Hawlina – Slovenia, University Eye Hospital of Ljubljana

• Nicole Eter – Germany, Euretina President

• Jens Folke Kiilgaard – Denmark, Euretina President Elect

• Martin Zinkernagel – Switzerland, Euretina General Secretary

• Anat Loewenstein – Israel, Euretina Past President

Please contact the organizer for further information.